Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes

Journal of Medical Virology

Volumn 70, Issue 2, 2003, Pages 301-308

  Hancock, Gerald E ^a   Tebbey, Paul W ^a   Scheuer, Catherine A ^a   Pryharski, Karin S ^a   Heers, Kristen M ^a   LaPierre, Natisha A ^a  

^a PFIZER INC   (United States)

Author keywords

Eosinophil; Peptide mapping; Type 2 T cells; Vaccine

Indexed keywords

ATTACHMENT GLYCOPROTEIN; EPITOPE; GLYCOPROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 5; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; ECTODOMAIN; FEMALE; GLYCOSYLATION; HAPLOTYPE; IMMUNE RESPONSE; INBRED STRAIN; LOEFFLER PNEUMONIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NONHUMAN; PEPTIDE MAPPING; PHENOTYPE; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENSITIZATION; SPLEEN CELL; T LYMPHOCYTE; TH2 CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; EOSINOPHILIA; EPITOPE MAPPING; GLYCOSYLATION; H-2 ANTIGENS; HAPLOTYPES; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHENOTYPE; PULMONARY EOSINOPHILIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TH2 CELLS; VACCINES, ATTENUATED; VIRAL PROTEINS; VIRAL VACCINES;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0037410254     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10395     Document Type: Article

References (35)

1. Bendelja K, Gagro A, Bace A, et al. 2000. Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol 121:332-338.
2. Cherrie AH, Anderson K, Wertz GW, Openshaw PJ. 1992. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J Virol 66:2102-2110.
3. Conzelmann KK. 1998. Negative-strand RNA viruses: genetics and manipulation of viral genomes. Annu Rev Genet 32:123-162.
4. Douglass JA, O'Hehir RE. 2000. What determines asthma phenotype? Respiratory infections and asthma. Am J Respir Crit Care Med 161:S211-S214.
5. Finkelman FD, Holmes J, Katona IM, Urban JFJ, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Ann Rev Immunol 8:303-333.
6. Garcia-Beato R, Melero JA. 2000. The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner. J Gen Virol 81:919-927.
7. Gorman JJ, Ferguson BL, Speelman D, Mills J. 1997. Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci 6:1308-1315.
8. Graham BS, Johnson TR, Peebles RS. 2000. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48:237-247.
9. Hall CB. 2001. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344:1917-1928.
10. Han LL, Alexander JP, Anderson LJ. 1999. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 179:25-30.
11. Hancock GE, Speelman DJ, Frenchick PJ, Mineo-Kuhn MM, Baggs RB, Hahn DJ. 1995. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in BALB/c mice that are similar to those generated by experimental infection. Vaccine 13:391-400.
12. Hancock GE, Speelman DJ, Heers K, Bortell E, Smith J, Cosco C. 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus. J Virol 70:7783-7791.
13. Hancock GE, Smith JD, Heers KM. 2000. Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus. J Infect Dis 181:1768-1771.
14. Hancock GE, Scheuer CA, Sierzega R, Pryharski KS, McBride JT, Watelet LF, Tebbey PW, Smith JD. 2001. Adaptive immune responses of patients with asthma to the attachment (G) glycoprotein of respiratory syncytial virus. J Infect Dis 184:1589-1593.
15. Holt PG. 2000. Key factors in the development of asthma: atopy. Am J Respir Crit Care Med 161:S172-S175.
16. Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJ. 1998. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J Immuno 16:6215-6222.
17. Jackson M, Scott R. 1996. Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines after stimulation with RS virus and RS virus proteins. J Med Virol 49:161-169.
18. Kapikian AZ, Mitchell RH, Chanock RM, Shevdoff RA, Stewart CE. 1968. An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89:405-413.
19. Kim HW, Leikin SL, Arrobio J, Brandt CD, Chanock RM, Parrott RH. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or infection. Pediatr Res 10:75-78.
20. Lammas DA, Mitchell LA, Wakelin D. 1989. Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis. Clin Exp Immunol 77:137-143.
21. Moss B. 1996. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA 93:11341-11348.
22. Murphy BR, Prince GA, Walsh EE, Kim HW, Parrott RH, Hemming VG, Rodriguez WJ, Chanock RM. 1986. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 24:197-202.
23. Newman MJ, Wu JY, Gardner BH, Munroe KJ, Leombruno D, Recchia J, Kensil CR, Coughlin RT. 1992. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J Immunol 148:2357-2362.
24. Rabatic S, Gagro A, Lokar-Kolbas R, et al. 1997. Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus. J Infect Dis 175:32-37.
25. Reiner SL, Locksley RM. 1995. The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151-177.
26. Renzi PM, Turgeon JP, Yang JP, et al. 1997. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. Pediatrics 130:584-593.
27. Roman M, Calhoun WJ, Hinton KL, et al. 1997. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 156:190-195.
28. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. 2001. Glycosylation and the immune system. Science 29:2370-2376.
29. Sigurs N. 2001. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am J Respir Crit Care Med 163:S2-S6.
30. Sparer TE, Matthews S, Hussell T, Rae AJ, Garcia-Barreno B, Melero JA, Openshaw PJ. 1998. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med 187:1921-1926.
31. Srikiatkhachorn A, Chang W, Braciale TJ. 1999. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent. J Virol 73:6590-6597.
32. Tebbey PW, Hagen M, Hancock GE. 1998. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J Exp Med 188:1967-1972.
33. Varga SM, Wissinger EL, Braciale TJ. 2000. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. J Immunol 165:6487-6495.
34. Varga SM, Wang X, Welsh RM, Braciale TJ. 2001. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4+ T cells. Immunity 15:637-646.
35. Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 75:9044-9058.